Unitaid investment expands our work on access to medicines
ITPC is delighted to be named one of three successful grantees of a new three year investment from Unitaid to...
Read more about Unitaid investment expands our work on access to medicines
Argentina’s drastic austerity measures puts lives at stake
This week (3 Aug 2018) Argentina’s President, Mauricio Macri, announced sweeping austerity measures. These cuts include slashing the budget for...
Read more about Argentina’s drastic austerity measures puts lives at stake
The people against Gilead. Activists protest at the Brazilian patent office, calling for Gilead’s last sofosbuvir patent application to be rejected
Activists gathered at the Brazilian Patent Office (INPI) in Rio de Janeiro this week, and Gilead’s office in São Paulo....
Read more about The people against Gilead. Activists protest at the Brazilian patent office, calling for Gilead’s last sofosbuvir patent application to be rejected
Overpatented, overpriced: How excessive pharmaceutical patenting is extending monopolies and driving up drug prices
This new report by our partner I-MAK analyzes the twelve best selling drugs in the United States and shows how...
Read more about Overpatented, overpriced: How excessive pharmaceutical patenting is extending monopolies and driving up drug prices
Dear Viiv, we’ve fixed your AIDS 2018 ‘letter’.
We thought ViiV’s large, expensive advert outside AIDS 2018 in Amsterdam needed some re-working. Such a shame to spend all...
Read more about Dear Viiv, we’ve fixed your AIDS 2018 ‘letter’.
Stockouts in Argentina threaten continuation of HIV treatments
One of the costly side-effects of Argentina’s economic crisis is the stockout of essential medicines, with HIV and Hepatitis C...
Read more about Stockouts in Argentina threaten continuation of HIV treatments
Connect with us at AIDS 2018 – & increase access to HIV treatment!
Are you going to be at the International AIDS Conference (AIDS2018) in Amsterdam, or following from afar? Here’s how to...
Read more about Connect with us at AIDS 2018 – & increase access to HIV treatment!
The problem with high drug prices isn’t ‘foreign freeloading,’ it’s the patent system
Today’s drug patent monopolies are stronger than at any point in the last century, raising prescription prices, reports Tahir Amin...
Read more about The problem with high drug prices isn’t ‘foreign freeloading,’ it’s the patent system
IP-Watch Q&A with Carlos Correa: The myth of IP incentives for all nations
Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property,...
Read more about IP-Watch Q&A with Carlos Correa: The myth of IP incentives for all nations
IP-Watch Q&A with Othoman Mellouk: The myth behind health and trade agreements
Othoman Mellouk is the Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC), and campaign...
Read more about IP-Watch Q&A with Othoman Mellouk: The myth behind health and trade agreements